QbTest has been announced as one of 11 innovations selected to join the award-winning NHS Innovation Accelerator (NIA) in 2020.
At a launch event chaired by Professor Stephen Powis, National Medical Director for NHS England and NHS Improvement, the 2020 cohort of Fellows presented their innovations to key stakeholders, including Tony Young, National Clinical Lead for Innovation of NHS England and NHS Improvement, and Nigel Edwards, Chief Executive of the Nuffield Trust, both of whom also spoke at the event.
The innovations joining the NIA this year offer solutions supporting priority areas for England’s NHS as laid out in the NHS Long Term Plan. Their recruitment follows an international call and rigorous selection process, including review by over 100 clinical, patient and commercial assessors, an informal review by the National Institute for Health and Care Excellence (NICE), interviews, and due diligence.
QbTest has been selected as one of the 11 innovations to be supported by this programme over the next 12 months. QbTest is our most advanced test for Attention Deficit Hyperactivity Disorder (ADHD). Used alongside rating scales and clinical interviews, QbTest has been shown to speed up the time to diagnostic decision, enable early intervention and significantly reduce costs for NHS trusts.
The appointment follows a rigorous, multi-stage selection process and means we will be supported to scale nationally over the next 3 years:
Click image to enlarge
The announcement marks the fifth year of the NIA, which is an NHS England initiative delivered in partnership with England’s 15 Academic Health Science Networks (AHSNs), hosted at UCLPartners. Since 2015, it has supported the uptake and spread of 62 evidence-based innovations across more than 2,210 NHS sites.
Professor Stephen Powis, National Medical Director for NHS England and NHS Improvement, said:
“The NHS Long Term Plan puts the latest technology and innovation at the heart of people’s care and the future of our health service… Right across the NHS patients are benefitting from world-beating innovations, spread as part of this programme, and now even more patients will be supported by new tools”.
Piers Ricketts, Chair of the AHSN Network, said:
“The NHS Innovation Accelerator is one of the flagship programmes of the AHSN Network. NIA Fellows have made a huge contribution to our health and care system since we started the programme five years ago, and we are proud to have supported these remarkable individuals on their development journey. It is gratifying to see their high-impact innovations gaining traction and visibility through our accelerator programme, and we are delighted that several NIA innovations have now had national impact in the NHS. We look forward to working with the new NIA Fellows to help them scale and deploy their innovations across the country for the benefit of patients and the NHS.”
Tony Doyle, Managing Director of Qbtech, said:
“we are incredibly proud to have been selected by the NIA. Most of all, we are excited for patients who will benefit the most from these innovations. For ADHD specifically, this is an important stepping stone in speeding up the time to diagnosis for those thought to have ADHD”.
The 11 innovations selected to join the NIA in 2020 are:
- QbTest: A CE-marked, FDA approved medical device that simultaneously measures attention, impulsivity and motor activity to speed up ADHD diagnosis and improve treatment evaluation
- Fibricheck: A medically certified app (CE Class IIA, FDA approved) capable of the early detection of heart rhythm disorders, such as atrial fibrillation, using a smartphone or smartwatch
- Health Navigator: AI-guided proactive health coaching to prevent avoidable urgent and emergency care
- Locum’s Nest: Award-winning software platform aiming to solve the staffing crisis through total workforce mobility by connecting healthcare professionals to vacant work
- Management and Supervision Tool (MaST): A dashboard that uses predictive analytics to generate insights which support staff to deliver high quality, effective mental health care
- MediShout: The world’s first platform to integrate all logistical departments in hospitals, giving clinicians an app to instantly report issues and using AI to predict future problems
- MyPreOp: A cloud-hosted programme enabling patients to enter, own and share their preoperative assessment information
- Patient Experience Platform (PEP): AI platform transforming healthcare and improving safety by empowering the digital voice of patients
- RIX Wiki: Software that enables people with learning disabilities to share personal health and care information for effective person-centred support in their communities
- Safe Steps: Reducing the number of preventable falls in the ageing population through digital, evidence-based interventions
- The WaterDrop: A low-cost, high impact innovation that enables patients to easily access fluids at any time without needing to call for help helping prevent dehydration and avoidable intravenous drips
About the NHS Innovation Accelerator
The NHS Innovation Accelerator (NIA) is an award-winning NHS England initiative delivered in partnership with England’s 15 Academic Health Science Networks (AHSNs), hosted at UCLPartners. It supports delivery of the NHS Long Term Plan priorities by accelerating uptake of high impact innovations for patient, population and NHS staff benefit, and providing practical insights on spread to inform national strategy.
Since it launched in July 2015, the NIA has supported 60 Fellows representing 62 innovations. Over 2,210 additional NHS sites are now using NIA innovations, £134.8m external funding has been raised, 468 jobs created, 113 awards won, and 45 NIA innovations are selling internationally.